Clinical Endogenous Cannabinoid Difficiency(CECD) and Medical Marijuana

Clinical Endocannabinoid Deficiency (CECD): Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions?

Abstract

OBJECTIVES: This study examines the concept of clinical endocannabinoid deficiency(CECD), and the prospect that it could underlie the pathophysiology of migraine, fibromyalgia, irritable bowel syndrome, and other functional conditions alleviated by clinical cannabis.

METHODS: Available literature was reviewed, and literature searches pursued via the National Library of Medicine database and other resources.

RESULTS: Migraine has numerous relationships to endocannabinoid function. Anandamide (AEA) potentiates 5-HT1A and inhibits 5-HT2A receptors supporting therapeutic efficacy in acute and preventive migraine treatment. Cannabinoids also demonstrate dopamine-blocking and anti-inflammatory effects. AEA is tonically active in the periaqueductal gray matter, a migraine generator. THC modulates glutamatergic neurotransmission via NMDA receptors. Fibromyalgia is now conceived as a central sensitization state with secondary hyperalgesia. Cannabinoids have similarly demonstrated the ability to block spinal, peripheral and gastrointestinal mechanisms that promote pain in headache, fibromyalgia, IBS and related disorders. The past and potential clinical utility of cannabis-based medicines in their treatment is discussed, as are further suggestions for experimental investigation of CECD via CSF examination and neuro-imaging.

CONCLUSION: Migraine, fibromyalgia, IBS and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines.

Cannabis TV Documentaries:

Hemp for Victory

Reefer Madness

The BEST Cannabis / Marijuana Propaganda Films / Movies of ALL TIME!

Marijuana: A Chronic History Presented by the History Channel

NGC’s Drugs Inc.: Marijuana

NGC’s Marijuana Nation

PBS’ Botany of Desire

CNBC’s Marijuana Inc.

TEA Party Eat your Heart Out!! The Bundy’s Were Here 1st!!

Links:

Peer Reviewed Research

MMJ Clinics / Doctors Recommendations

MMJ Dispensaries/Caregivers: Find Them Here

MMJ Strains / Varieties: Find Them Here Potency Tested

Ed Rosenthal Runs For President in 2012? Stephen’s Colbert SuperPac Funding?

Fastest way to determine cannabis seedling sex!

Grow Buddy Thin Layer Chromatography THC, CBD test kit

Grow Buddy Instructional Video

Grow Buddy Replacement T.L.C. Supplies

Plant DNA Collection Kit

Montana Biotech Products and Services

Cannabinoid Facts

Specialist Want Regulations / Oversight of Medical Marijuana Analysis Labs, Montana Biotech Embraces Open Dialog

Cannalytics™ Cannabinoid Fingerprinting Test by Alpha Nova vs Grow Buddy™ at Home THC, CBD, CBN Test Kit by Montana Biotech Comparing Two Competing Thin Layer Chromatography T.L.C Methods

QUALTITATIVE vs. QAUNTITATIVE Analysis of Cannabis THC, CBD, CBN Cannabinoid Levels

Ed Rosenthal and the Party-Party’s Platform for America 2012!

A Little Ed History and Education! Wiki Style!

Call Montana Biotech today for more information on setting up a Grow Room Help or consultation!

Cell: 406-600-6871

E-Mail: MontanaBiotech@gmail.com

Twitter: @MontanaBiotech

Facebook: http://www.facebook.com/joseph.lacerenza

Donate to Cannabis Research at Montana Biotech

Advertisements

One thought on “Clinical Endogenous Cannabinoid Difficiency(CECD) and Medical Marijuana

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s